Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 500 results in range #251 to #750.
View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)
- Tumour suppressor gene (1 revision)
- National DRL (1 revision)
- ICRP Publication 25 (1 revision)
- ICRP Publication 31 (1 revision)
- Deterministic effect (1 revision)
- Oxygen enhancement ratio (1 revision)
- ICRP Publication 46 (1 revision)
- Population risk (1 revision)
- ICRP Publication 60 (1 revision)
- Dose modifying factor (1 revision)
- ICRP Publication 75 (1 revision)
- ICRP Publication 9 (1 revision)
- 1934 Recommendations (1 revision)
- Access control (1 revision)
- Registry (1 revision)
- General Information: Radon (1 revision - redirect page)
- ICRP Publication 96 (1 revision)
- Secondary radiation (1 revision)
- Intake (1 revision)
- ICRP Publication 108 (1 revision)
- Brachytherapy (1 revision)
- Standard-size adult (1 revision)
- ICRP Publication 121 (1 revision)
- Case–control study (1 revision)
- ICRP Publication 137 (1 revision)
- ICRP Publication 151 (1 revision)
- National radon survey (1 revision)
- ICRP Publication 26 (1 revision)
- DS86 (1 revision)
- ICRP Publication 32 (1 revision)
- ICRP Publication 47 (1 revision)
- Potential alpha energy concentration (1 revision)
- ICRP Publication 61 (1 revision)
- ICRP Publication 76 (1 revision)
- Equilibrium equivalent concentration (1 revision)
- Expanded radiation field (1 revision)
- 1937 Recommendations (1 revision)
- Redox (1 revision)
- Adventitious source (1 revision)
- ICRP Publication 97 (1 revision)
- Annual intake (1 revision)
- Secretory cells (1 revision)
- Intensity-modulated radiotherapy (1 revision)
- ICRP Publication 109 (1 revision)
- Stem cell (1 revision)
- Kerma approximation (1 revision)
- ICRP Publication 122 (1 revision)
- Targeted effects (1 revision)
- ICRP Publication 138 (1 revision)
- Collimation (1 revision)
- ICRP Publication 152 (1 revision)
- Typical value (1 revision)
- ICRP Publication 27 (1 revision)
- ICRP Publication 33 (1 revision)
- Detriment-adjusted risk (1 revision)
- Particle transport (1 revision)
- ICRP Publication 48 (1 revision)
- Dose-response function (1 revision)
- ICRP Publication 62 (1 revision)
- ICRP Publication 77 (1 revision)
- Equilibrium factor (1 revision)
- 1950 Recommendations (1 revision)
- Relative biological effectiveness (1 revision)
- ICRP Publication 98 (1 revision)
- Backscatter factor (1 revision)
- Somatic effect (1 revision)
- ICRP Publication 10A (1 revision)
- ICRP Publication 123 (1 revision)
- Charged-particle equilibrium (1 revision)
- ICRP Publication 139 (1 revision)
- Tolerance dose (1 revision)
- ICRP Publication 153 (1 revision)
- ICRP Publication 28 (1 revision)
- Occupancy factor (1 revision)
- ICRP Publication 34 (1 revision)
- ICRP Publication 49 (1 revision)
- ICRP Publication 63 (1 revision)
- ICRP Publication 78 (1 revision)
- Elemental dose (1 revision)
- Radon-prone area (1 revision)
- Exposed individuals (1 revision)
- 1954 Recommendations (1 revision)
- Reference Person (1 revision)
- Relative life lost (1 revision)
- ICRP Publication 99 (1 revision)
- Apoptosis (1 revision)
- Security screening (1 revision)
- ICRP Publication 11 (1 revision)
- Stochastic effect (1 revision)
- ICRP Publication 124 (1 revision)
- ICRP Publication 125 (1 revision)
- Teratocarcinoma (1 revision)
- Low dose (1 revision)
- ICRP Publication 14 (1 revision)
- Commissioning (1 revision)
- ICRP Publication 154 (1 revision)
- Cosmic radiation (1 revision)
- ICRP Publication 29 (1 revision)
- ICRP Publication 35 (1 revision)
- ICRP Publication 5 (1 revision)
- Dose-threshold hypothesis (1 revision)
- Potentially lethal damage repair (1 revision)
- ICRP Publication 64 (1 revision)
- ICRP Publication 79 (1 revision)
- 1956 Recommendations (1 revision)
- Activation (1 revision)
- Relative risk (1 revision)
- Ring chromosome (1 revision)
- ICRP Supporting Guidance 2 (1 revision)
- ICRP Publication 1 (1 revision)
- Baseline disease rates (1 revision)
- International Commission on Radiological Protection (1 revision)
- ICRP Publication 110 (1 revision)
- Breakpoint cluster region/abelson (1 revision)
- Lag (1 revision)
- Late normal tissue responses (1 revision)
- ICRP Publication 126 (1 revision)
- ICRP Publication 140 (1 revision)
- ICRP Publication 155 (1 revision)
- ICRP Publication 3 (1 revision)
- Α/β value (1 revision)
- Oncogene (1 revision)
- ICRP Publication 36 (1 revision)
- Dicentric chromosome (1 revision)
- ICRP Publication 50 (1 revision)
- Dose and dose-rate effectiveness factor (1 revision)
- ICRP Publication 65 (1 revision)
- ICRP Publication 8 (1 revision)
- 1959 Decisions (1 revision)
- Relative survival (1 revision)
- Hereditary effect (1 revision)
- ICRP Publication 10 (1 revision)
- Source region (1 revision)
- ICRP Publication 111 (1 revision)
- Latent time/period or latency interval (2 revisions)
- Class SR-2 gases (2 revisions)
- Low level waste (2 revisions)
- Committed equivalent dose (2 revisions)
- Dichotomous (2 revisions)
- Dose rate effectiveness factor (2 revisions)
- Qualified expert (2 revisions)
- Emergency plan (2 revisions)
- Radioactive substance (2 revisions)
- Ethics (2 revisions)
- ALARA (2 revisions)
- Reference biokinetic model (2 revisions)
- Relocation (2 revisions)
- Risk coefficient (2 revisions)
- Hierarchical tissues (2 revisions)
- Area monitoring (2 revisions)
- Individual monitoring (2 revisions)
- Benthic (2 revisions)
- Source term (2 revisions)
- Bronchial region (2 revisions)
- Substantial radiation dose level (2 revisions)
- Clearance (2 revisions)
- Transfer rate (2 revisions)
- Multi-detector computed tomography (2 revisions)
- Deontological Ethics (2 revisions)
- Differentiation (2 revisions)
- Percutaneous coronary intervention (2 revisions)
- Prevailing circumstances (2 revisions)
- Radon Recommendations for Authorities (2 revisions)
- Reference individual (2 revisions)
- Activity (2 revisions)
- Remedial action (2 revisions)
- ICRPædia Guide to Dose Coefficients (2 revisions)
- High level waste (2 revisions)
- Intervention Level (2 revisions)
- Clearance level (2 revisions)
- Lymphatic system (2 revisions)
- Transforming growth factor (2 revisions)
- Pericarditis (2 revisions)
- Dose constraint (2 revisions)
- Principle of application of dose limits (2 revisions)
- Early normal tissue responses (2 revisions)
- Radioactivity (2 revisions)
- Radon Recommendations for Workplaces (2 revisions)
- Reference level (2 revisions)
- Remediation (2 revisions)
- Risk of Exposure to Radon (2 revisions)
- Beta-minus decay (2 revisions)
- South Atlantic anomaly (2 revisions)
- Interventional procedure (2 revisions)
- Lifetime risk (2 revisions)
- Macrophage colony stimulating factor (2 revisions)
- Multiplicative risk projection model (2 revisions)
- Cumulative dose (2 revisions)
- Dose conversion coefficient (2 revisions)
- Edema (2 revisions)
- Excess relative risk (2 revisions)
- Exposure situation (2 revisions)
- Repopulation (2 revisions)
- Growth factor (2 revisions)
- Alimentary tract transfer factor (2 revisions)
- Routine monitoring (2 revisions)
- ICRPædia Guide to Radon (2 revisions)
- Beta-plus decay (2 revisions)
- Special (non-routine) monitoring (2 revisions)
- Calculating Doses from Intakes of Radionuclides (2 revisions)
- Clonogenic cells (2 revisions)
- Threshold dose for tissue reactions (2 revisions)
- Magnetosphere (2 revisions)
- Curie (2 revisions)
- Effect Dose 50 (2 revisions)
- Endogeneous excretion (2 revisions)
- Radiographer (2 revisions)
- Exposure to Radon at Home (2 revisions)
- GATA binding protein 2 (2 revisions)
- Representative organism (non-human biota) (2 revisions)
- ICRPædia Guide to the Basics of Ionising Radiation (2 revisions)
- Hormones (2 revisions)
- Authorization (2 revisions)
- Limitation of dose (2 revisions)
- Clonogenic survival (2 revisions)
- Transmission detection system (2 revisions)
- Multistage tumorigenesis (2 revisions)
- Cytokines (2 revisions)
- Non-sphericity parameter (2 revisions)
- Pharynx (2 revisions)
- Acute radiation syndrome (2 revisions)
- Representative person (2 revisions)
- Safety (2 revisions)
- Hounsfield unit (2 revisions)
- Authorized limit (2 revisions)
- Specific effective energy (2 revisions)
- Cardiac arrhythmias (2 revisions)
- Lineal energy (2 revisions)
- Thyroid blocking (2 revisions)
- Transparency (2 revisions)
- Waste disposal (2 revisions)
- Non-targeted effects (2 revisions)
- Disposal (2 revisions)
- Dose criteria (2 revisions)
- Procedural values (2 revisions)
- Environmental exposure (2 revisions)
- Exempt waste (2 revisions)
- Adaptive response (2 revisions)
- Reproductive integrity (2 revisions)
- Alveolar-interstitial region (2 revisions)
- Safety case (2 revisions)
- Autoimmune disease (2 revisions)
- Slow repair (2 revisions)
- Isotropic geometry (2 revisions)
- ICRP Publication 118 (2 revisions)
- Cardiac valve diseases (2 revisions)
- Linear-non-threshold model (2 revisions)
- Co-expertise (2 revisions)
- Connective tissue (2 revisions)
- Trapped particles (2 revisions)
- DRL process (2 revisions)
- Orphan source (2 revisions)
- Planned exposure situation (2 revisions)
- Progenitor cell (2 revisions)
- Radiation belt (2 revisions - redirect page)
- Environmental radiation protection (2 revisions)
- Exemption level (2 revisions)
- Reasonableness (2 revisions)
- Residual dose (2 revisions)
- Safety culture (2 revisions)
- Solar cosmic radiation (2 revisions)
- Inhalability (2 revisions)
- Spontaneous fission (2 revisions)
- Itinerant (radiation) worker (2 revisions)
- Systemic model (2 revisions)
- Linear-quadratic dose response model (2 revisions)
- Time factor (2 revisions)
- Consequential late effects (2 revisions)
- Myocardial perfusion (2 revisions)
- What is Radon? (2 revisions)
- Platelet-derived growth factor (2 revisions)
- Effective dose equivalent (2 revisions)
- Radiation modifier (2 revisions)
- Radiological protection principles (2 revisions)
- Existing exposure situation (2 revisions)
- Gastroschisis (2 revisions)
- Respiratory protection (2 revisions)
- Angiogenesis (2 revisions)
- Scintigraphy (2 revisions)
- Hyperbaric oxygen (2 revisions)
- Solar cycle (2 revisions)
- Inner bremsstrahlung (2 revisions)
- Bioturbation (2 revisions)
- Cardioverter-defibrillator (2 revisions)
- Tachycardia (2 revisions)
- Cohort study (2 revisions)
- Tissue equivalent material (2 revisions)
- Myocardial stress test (2 revisions)
- DRL value (2 revisions)
- Oversight (2 revisions)
- Projected dose (2 revisions)
- Epithelium (2 revisions)
- Radionuclides of natural origin (2 revisions)
- Recovery (cellular or tissue) (2 revisions)
- Acceptance test (2 revisions)
- Gastrulation (2 revisions)
- Retrievability (2 revisions)
- Habitual mouth breather (2 revisions)
- Annihilation photons (2 revisions)
- Immune system (2 revisions)
- Hyperfractionation (2 revisions)
- Institutional control (2 revisions)
- Bone marrow (2 revisions)
- Stakeholder (2 revisions)
- Containment (2 revisions)
- Worker (2 revisions)
- Nuclear track detectors (2 revisions)
- Dose-length product (2 revisions)
- Radiation safety officer (2 revisions)
- Equieffective dose (2 revisions)
- Radioresponsiveness (2 revisions)
- Expanded and aligned radiation field (2 revisions)
- Recovery responder (2 revisions)
- Adventitious (2 revisions)
- Reversibility (2 revisions)
- Habitual nose breather (2 revisions)
- In vivo radiobioassay (2 revisions)
- Hypertrophic cardiomyopathy (2 revisions)
- Background dose (rate) (2 revisions)
- Solar particle event (2 revisions)
- Target tissue (2 revisions)
- Measuring and Reducing Radon Levels in your Home (2 revisions)
- Working level (2 revisions)
- OLINDA/EXM (2 revisions)
- Detriment (2 revisions)
- Particle radiance (2 revisions)
- Dose-rate effect (2 revisions)
- Protection strategy (2 revisions)
- Electron-capture decay (2 revisions)
- Radiation source (2 revisions)
- Radiosensitiser (2 revisions)
- Fluoroscopically or computed tomography guided interventions (2 revisions)
- Rehabilitation of living conditions (2 revisions)
- Right to know (2 revisions)
- Incidence (2 revisions)
- Hypoplasia (2 revisions)
- Backscatter detection system (2 revisions)
- Solar wind (2 revisions)
- Bradycardia (2 revisions)
- Local DRL (2 revisions)
- Tolerability (2 revisions)
- Medical exposure (2 revisions)
- Coronary heart disease (2 revisions)
- Naturally occurring radioactive material (2 revisions)
- Decay constant (2 revisions)
- Working level month (2 revisions)
- Dose of record Hp (10) (2 revisions)
- Electrophysiology (2 revisions)
- Radiosensitivity, cellular (2 revisions)
- Accreditation (2 revisions)
- Genomic integrity (2 revisions)
- Rigidity (2 revisions)
- Hazard (2 revisions)
- Security (2 revisions)
- Incident (2 revisions)
- Intermediate level waste (2 revisions)
- Bragg peak (2 revisions)
- Stenosis (2 revisions)
- Chronic exposure (2 revisions)
- Telangiectasia (2 revisions)
- Colony (2 revisions)
- Member of the public (2 revisions)
- Cosmic Radiation in Aviation (2 revisions)
- Unattached fraction (2 revisions)
- Necrosis (2 revisions)
- Decommissioning (2 revisions)
- Patient entrance reference point (2 revisions)
- Dose-threshold (2 revisions)
- Potential recoverability correction factor (2 revisions)
- Protective action guide (2 revisions)
- Radiation worker (2 revisions)
- Fractional absorption in the gastrointestinal tract (2 revisions)
- Action Level (2 revisions)
- Health Surveillance (2 revisions)
- Inclusiveness (2 revisions)
- Basal cell (2 revisions)
- Source-related (2 revisions)
- Internal conversion electron (2 revisions)
- Branching fraction (2 revisions)
- LD 50/30 (2 revisions)
- Class SR-0 gases (2 revisions)
- Track structure (2 revisions)
- Mendelian diseases (2 revisions)
- Neurological syndrome (2 revisions)
- Decontamination (2 revisions)
- Occupational exposure (2 revisions)
- Diastasis (2 revisions)
- Peak skin dose (2 revisions)
- Dose per unit intake coefficient (2 revisions)
- Emergency (2 revisions)
- Radioactive dispersion device (2 revisions)
- Radon: Units of Measure (2 revisions)
- Exposure, external or internal (2 revisions)
- Reference air kerma (2 revisions)
- Graft vs host disease (2 revisions)
- Air-kerma, incident (2 revisions)
- Heliosphere (2 revisions)
- Self-help protection (2 revisions)
- Individual-related (2 revisions)
- Storage (2 revisions)
- Class SR-1 gases (2 revisions)
- Low dose rate (2 revisions)
- Committed effective dose (2 revisions)
- Transfer compartment (2 revisions)
- Mitigation (2 revisions)
- Cost-benefit analysis (2 revisions)
- Upper reference levels (2 revisions)
- Neurovascular syndrome (2 revisions)
- Decontamination factor (2 revisions)
- Pelagic (2 revisions)
- Practical radiological protection culture (2 revisions)
- Dose rate (2 revisions)
- Emergency exposure situation (2 revisions)
- Radioactive source (2 revisions)
- Erythropoietin (2 revisions)
- Exposure (in the context of inhalation) (2 revisions)
- Fractionation and dose delivery patterns (2 revisions)
- ICRP Task Groups on Radiological Protection in Healthcare (2 revisions)
- Individual decontamination (2 revisions)
- Broad beam therapy irradiation technique (2 revisions)
- Subcutaneous tissue (2 revisions)
- Coster-Kronig transition (3 revisions)
- Uptake (3 revisions)
- Granulocyte colony-stimulating factor (3 revisions)
- Utilitarian ethics (3 revisions)
- Operational quantity (3 revisions)
- Emergency preparedness (3 revisions)
- Gray (3 revisions)
- Value judgement (3 revisions)
- Emergency procedures (3 revisions)
- Absolute risk (3 revisions)
- Auger transition (3 revisions)
- Bystander effect (3 revisions)
- Complex tissues (3 revisions)
- Valvular heart disease (3 revisions)
- Derived air concentration (3 revisions)
- Dignity (3 revisions)
- Personal dose equivalent (3 revisions)
- Principle of justification (3 revisions)
- Employer (3 revisions)
- Radiofrequency ablation (3 revisions)
- Activity median thermodynamic diameter (3 revisions)
- Lifetime risk estimates (3 revisions)
- Virtue ethics (3 revisions)
- Growth fraction (3 revisions)
- Iso-effect plots (3 revisions)
- Voxel phantom (3 revisions)
- Radiological Protection in Healthcare (3 revisions - redirect page)
- Excretion rate (instantaneous) (3 revisions)
- Extrathoracic airways (3 revisions)
- Galactic cosmic radiation (3 revisions)
- Growth hormone (somatotropin) (3 revisions)
- ICRP Publication 103 (3 revisions)
- Isomers (3 revisions)
- DNA damage signalling (3 revisions)
- Organ dose equivalent (3 revisions)
- Fairness (3 revisions)
- Absorption (3 revisions)
- Gamma ray (3 revisions)
- Dose equivalent (3 revisions)
- Field-size effect (Volume effect) (3 revisions)
- Gastrointestinal syndrome (3 revisions)
- Biomedical research volunteer (3 revisions)
- Cardiomyopathy (3 revisions)
- Dose limit (3 revisions)
- Recovery (3 revisions)
- Flexible tissues (3 revisions)
- Guide to the System of Radiological Protection (3 revisions)
- Autonomy (3 revisions)
- Spread-out Bragg peak (3 revisions)
- Constancy test (3 revisions)
- Wisdom (3 revisions)
- Dose (3 revisions)
- Dose limits (3 revisions)
- Fluence (3 revisions)
- Target region (3 revisions)
- DS02 (3 revisions)
- Fluoroscopically guided interventions (3 revisions)
- Annual dose (3 revisions)
- Contamination (3 revisions)
- Dose of record (E) (3 revisions)
- Accountability (3 revisions)
- Half-life, physical (3 revisions)
- Cell death (3 revisions)
- Potential exposure (3 revisions)
- Exponential survival curve (3 revisions)
- Annual limit on intake (3 revisions)
- Low Earth orbit (3 revisions)
- X ray (3 revisions)
- Dose per content function (3 revisions)
- Equity (3 revisions)
- Graded approach (3 revisions)
- Rigidity threshold (3 revisions)
- Unsealed source (3 revisions)
- Xerostomia (3 revisions)
- Fractionation (3 revisions)
- Test (3 revisions)
- Public exposure (3 revisions)
- Active (red) bone marrow (3 revisions)
- Granulocyte-macrophage colony-stimulating factor (3 revisions)
